Latest from Kromek

Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, is pleased to announce that one of its key customers, Spectrum Dynamics Medical, has introduced the world’s first digital SPECT/CT scanner for higher energy imaging, using Kromek’s digital detectors.

Kromek are pleased to be invited to this prestigious event, where Dr. Thomas Zillhardt from the University of Manchester will be showcasing results from our collaborative Quantum Digital Tomosynthesis project.

Kromek awarded supply contract by US based OEM customer, up to $17million contract awarded following successful progression of development program

Kromek is exhibiting and speaking at IEEE NSS MIC Virtual Event on 16th – 23rd October. We are very excited to present, for the first time, a new concept for a low-dose Molecular Breast Imaging (MBI) gamma camera.

Kromek, alongside Newcastle Upon Tyne Hospitals NHS Foundation Trust (NuTH), are showcasing their early phase research in understanding the problem of dense breasts within breast cancer screening in the UK at the 2021 Symposium Mammographicum conference next week (7th - 10th Feb).

Kromek announces that it has commenced a £1.25m programme funded by Innovate UK to customise its biological threat-detection solution for the automated detection of all airborne viruses, including COVID-19, to support end-use cases.